personalized medicine for dlbcl
Published 4 years ago • 35 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
0:42
targeted therapies for dlbcl treatment
-
1:02
the changing standard of care in dlbcl
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
1:05
identifying high-risk dlbcl and optimizing treatment for these patients
-
3:41
personalised medicine in cll: redefining the treatment approach
-
18:54
exploring the lab's vital role in healthcare
-
21:38
drawing the line: the rationale behind blood tube collection order
-
2:57
why do we need ai in the hematology clinic?
-
1:00
why is personalized medicine important for cll?
-
1:55
diagnosing and treating aml: the role of mutational profiling
-
1:46
towards a personalized treatment approach for scd
-
1:22
the future of cll treatment and more personalized approaches
-
0:46
the myeloma genome project: designing personalised therapy for mm
-
1:42
precision medicine for b-cell lymphomas
-
4:15
advances being made in the treatment of mcl: personalized therapy and combination approaches
-
16:57
clinical trials, pathologies and developments in personalized medicine
-
5:38
personalized medicine in multiple myeloma
-
1:05
personalized therapy in leukemia: a case study
-
1:59
moving towards a personalized treatment approach in cll